HARVARD BIOSCIENCE INC

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing for pharmaceutical and therapy development. The company sells its products and services globally to academic institutions, government laboratories, and pharmaceutical, biotechnology, and contract research organizations (CROs). Harvard Bioscience operates in the United States, Europe, and China, utilizing both direct and distribution channels to reach customers worldwide. The business began in 1901 as Harvard Apparatus, founded by Dr. William T. Porter. Early inventions included ventilators based on Dr. Porter's design, the mechanical syringe pump in the 1950s, and the microprocessor-controlled syringe pump in the 1980s. Harvard Bioscience, Inc. was incorporated in Delaware in September 2000 and became the successor to Harvard Apparatus, Inc. in November 2000. In 2018, the company acquired Data Sciences International, Inc. (DSI), a global leader in products, services, and solutions for preclinical testing. The DSI product portfolio complements Harvard Bioscience's cellular and molecular technology (CMT) product portfolio, expanding its offerings from research and discovery to preclinical testing, with primary applications in drug and therapy testing.